OnTrack Diabetes

OnTrack Diabetes offers innovative solutions for diabetes management, focusing on improving patient outcomes through modern data analytics and integrated health services. OnTrack Diabetes was founded in 1999 in Canada, primarily focusing on diabetes management solutions. In September 2013, the company was acquired by Medivo, a portfolio company of ARC Angel Fund, MentorTech Ventures, Merck Global Health Innovation Fund, and Safeguard Scientifics. The firm was co-founded by Destry Sulkes and Konstantina Tzelepi, with Sundeep Bhan serving as the CEO.

OnTrack Diabetes specializes in providing actionable clinical data aimed at enhancing diabetes management for both patients and healthcare providers. Their services include integrated health analytics tools designed to support effective treatment plans and improve adherence among patients. They leverage partnerships to deliver comprehensive data solutions that empower healthcare professionals with the insights needed for effective diabetes care. OnTrack Diabetes generates revenue primarily through partnerships with healthcare organizations and subscription models, offering access to its data and analytic tools.

The company's pricing models enable clients to engage with tailored solutions for diabetes management, allowing healthcare providers access to critical patient data to enhance care quality and improve outcomes. The company plans to expand its product offerings with new digital health tools aimed at diabetes monitoring and management slated for release in the coming year. Additionally, OnTrack Diabetes is targeting expansion into the North American healthcare market by the end of 2024. The recent acquisition by Medivo will facilitate these growth initiatives, allowing OnTrack to enhance its service delivery and reach more healthcare providers across the region.